NXL
NXL
NASDAQ · Health Care

Nexalin Technology Inc

$0.34
+0.00 (+0.74%)
As of May 16, 2:31 AM ET ·
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +2,373.0% upside
Low Target $5.74
Average Target $8.47
High Target $10.28
Current Price $0.34
Current
$0.34
Target
$8.47
$5.74 $8.47 avg $10.28
Scenario Analysis
Bear Case
$5.74
1,575.9%
Low target
Base Case
$8.47
+2,373.0%
Avg target
Bull Case
$10.28
+2,901.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.00
-82.9% from high
52-Week Low
$0.33
+3.7% from low
Target vs 52W High
$8.47
+323.5% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Strong Buy 34 76% $293.85 -25.4%
ISRG
Intuitive Surgical Inc
Buy 41 71% $219.77 -47.8%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +46.2%
CVS
Cvs Health Corp
Strong Buy 33 76% $162.09 +69.0%
SYK
Stryker Corp
Strong Buy 37 76% $338.36 +10.3%
MDT
Medtronic Plc
Buy 37 62% $192.46 +152.7%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -71.9%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -59.6%